tiprankstipranks
Advertisement
Advertisement
InMed Pharmaceuticals Lowers Exercise Price on Preferred Options
PremiumCompany AnnouncementsInMed Pharmaceuticals Lowers Exercise Price on Preferred Options
1M ago
InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
Premium
Company Announcements
InMed Highlights INM-901 Alzheimer’s Data in Q3 Update
2M ago
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
Premium
Company Announcements
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
2M ago
InMed Reports Positive Preclinical Data for Alzheimer’s Candidate
PremiumCompany AnnouncementsInMed Reports Positive Preclinical Data for Alzheimer’s Candidate
3M ago
InMed Pharmaceuticals announces preclinical data on effects of INM-901
Premium
The Fly
InMed Pharmaceuticals announces preclinical data on effects of INM-901
3M ago
InMed Pharmaceuticals files $50M mixed securities shelf
Premium
The Fly
InMed Pharmaceuticals files $50M mixed securities shelf
3M ago
InMed Shareholders Approve Directors and Equity Financing Flexibility
PremiumCompany AnnouncementsInMed Shareholders Approve Directors and Equity Financing Flexibility
6M ago
InMed Faces Challenges from New U.S. Legislation
Premium
Company Announcements
InMed Faces Challenges from New U.S. Legislation
6M ago
InMed Pharmaceuticals Completes Key Study for INM-901
Premium
Company Announcements
InMed Pharmaceuticals Completes Key Study for INM-901
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100